title: Correlation of HBV and HCV with CH, LC, HCC in liver biopsied tissue at Rajavithi Hospital.
abstract: Retrospective study in Clinicopathology of 66 surgical liver tissue from adult Thai patients admitted at Rajavithi Hospital, in Bangkok, during December 2002-September 2003 (10 month periods). The main purposes are: 1) To find the correlation of HBV, HCV with CH, LC, HCC. 2) To compare the correlation of Hepatocyte, AFP, CEA (IHC) in malignant cells, which one is the best usage to confirm the diagnosis of HCC in both primary and metastasis. 3) To review the clinicopathology of all these 66 liver samples. The results were significant correlation of HBsAg (serology) with HCC (p = 0.010), and also significant correlation of HBsAg (IHC in liver tissue) with CH, LC (p = 0.038, 0.021 respectively). Although no significant correlation (p > 0.05) of HCV (positive anti HCV) with CH, LC, HCC; the causes due to the small sample sizes and short period study are possibly bias factors. The authors concluded that Hepatocyte or Hep-Par I is the best immunocellular marker for malignant liver cells both in primary and metastasis (p < 0.001). The AFP, CEA show no correlation (p = 0.999, 0.670). The authors found other interesting non-viral related liver disease, common, uncommon, tumor and tumor-like (pseudotumor) lesions in the liver from the present study. The results of significant correlation of HBV (HBsAg) with CH, LC, HCC is one good evidence to further support The National HBV Vaccine Program for the uninfected population, which has been sponsored by the Thai Government, The Ministry of Public Health since 1992 and be one of the best and successful Thai Public-Health Policy.
authors.affiliation: Department of Pathology, Rajavithi Hospital, 2 Rajavithi Rd, Bangkok 10400, Thailand. komi@ksc.th.com
authors.forename: Arunluck
authors.initials: A
authors.lastname: Komindr
authors.forename: Niphon
authors.initials: N
authors.lastname: Praditphol
authors.forename: Suchada
authors.initials: S
authors.lastname: Suphanpayak
authors.forename: Rungarun
authors.initials: R
authors.lastname: Sae-Eaw
authors.forename: Ampai
authors.initials: A
authors.lastname: Nussati
authors.forename: Supatip
authors.initials: S
authors.lastname: Tujinda
authors.forename: Pranee
authors.initials: P
authors.lastname: Kongteeraphap
authors.forename: Sud
authors.initials: S
authors.lastname: Intaraksa
authors.forename: Renoo
authors.initials: R
authors.lastname: Rukchampong
authors.forename: Teera
authors.initials: T
authors.lastname: Deesawat
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000473:pathology*; D002648:Child; D005260:Female; D006509:Hepatitis B / Q000175:diagnosis / Q000473:pathology*; D006526:Hepatitis C / Q000175:diagnosis / Q000473:pathology*; D006521:Hepatitis, Chronic / Q000175:diagnosis / Q000473:pathology*; D006801:Humans; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D013223:Statistics as Topic; D013785:Thailand